Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06280534
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-10
Brief Title:
Safety Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects
Sponsor:
Xian Xintong Pharmaceutical Research CoLtd
Organization:
Xian Xintong Pharmaceutical Research CoLtd
Study Overview
Official Title:
Randomized Double-blind Single Center Phase Ia Study Evaluating the Safety Tolerability Pharmacokinetics and Food Effects of Single and Multiple Doses of XT1061 in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
XT1061
Brief Summary:
A Randomized Double-Blind Single-Center Phase Ia Study to Evaluate the Safety Tolerability Pharmacokinetics and Food Effects of Single and Multiple Doses of XT1061 in Healthy Subjects
Detailed Description:
This trial is a randomized double-blind dose-escalation placebo-controlled single-center clinical study designed to evaluate the safety tolerability pharmacokinetic profile and metabolic conversion of XT1061 in healthy subjects with single and multiple administrations as well as a study of the effect of food on pharmacokinetics
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None